Hematology/Oncology

Top Story

Undetected cirrhosis common at HCC diagnosis

February 9, 2016

In a U.S. Veteran population, a majority of patients with hepatocellular carcinoma had undetected cirrhosis at the time carcinoma was diagnosed. These patients were also more likely to have advanced stage HCC.

“The findings from the study may suggest that under-recognition of cirrhosis might, at least in part, explain the disconnection between the expected and observed benefits associated with HCC screening practices in the [U.S.],” the researchers wrote.

In the Journals

Unprovoked VTE may increase risk for subsequent cancer diagnosis

February 9, 2016
Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a population-based cohort…
In the Journals

ASCO: Biomarker assays demonstrate utility for early-stage invasive breast cancer

February 8, 2016
ASCO has issued a new clinical practice guideline that endorses the use of several biomarker assays to guide decisions on adjuvant systemic therapy for women with…
FDA News

FDA grants breakthrough therapy designation to IMMU-132 for triple-negative breast cancer

February 8, 2016
The FDA granted breakthrough therapy designation to sacituzumab govitecan for the treatment of patients with triple-negative breast cancer who have failed at least two…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent…
More News Headlines »
CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Video

VIDEO: Increase in cancer among younger patients requires vigilant screening techniques

January 27, 2016
More »
Featured
CME

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Current Issues
View the Current Issue
HemOnc Today